Pete, I use the Phase 2a timeline to estimate Phase 2b. It took ~10 weeks to unblind 115 patients in 2a. Assuming the same rate, it'll take ~17 weeks to unblind 199 patients in 2b. The trial ended on 12/20/2017. 17 weeks later will be mid-April, so we're getting there.
Of course, every CRO and trial sites work differently. I remember Dr. B said they chose the best CRO for dermatological trials, so I'm not worried about something went wrong during unblinding.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links